Moderna moves forward seeking FDA's approval for new flu vaccine after dispute
Moderna moves forward seeking FDA's approval for new flu vaccine after dispute
- Moderna's new flu vaccine was initially blocked by the FDA due to a dispute over a clinical trial.
- The vaccine has shown increased effectiveness for adults aged 50 and older, but the trial excluded a recommended vaccine for those 65 and older.
- Moderna is now seeking full approval for certain age groups and hopes to launch the vaccine later this year.
Story
impact shift geopolitical shift policy global data strategic impact geopolitical policy market data analysis market shift economic global policy impact impact policy insight policy geopolitical strategic market insight data geopolitical market shift strategic data market market economic policy policy trends geopolitical impact geopolitical market market data policy analysis insight analysis geopolitical geopolitical global trends global data geopolitical market insight impact insight data shift trends impact economic analysis data policy geopolitical impact insight insight global strategic geopolitical shift analysis economic geopolitical...
Context
strategic shift impact impact impact data insight policy strategic policy economic economic economic shift market shift shift impact economic data geopolitical policy global analysis insight trends impact trends strategic economic policy global data market policy policy impact analysis geopolitical global trends analysis global shift data insight strategic economic market impact global economic impact analysis strategic economic trends shift impact geopolitical global trends economic economic data geopolitical geopolitical global global shift insight trends analysis impact analysis shift global policy data geopolitical...
